Matsuhisa, Munehide

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Ueki, K., Sasako, T., Okazaki, Y., Kato, M., Okahata, S., Katsuyama, H., Haraguchi, M., Morita, A., Ohashi, K., Hara, K., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 313

Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes

Kaneto, H., Matsuoka, T.-A., Nakatani, Y., Kawamori, D., Miyatsuka, T., Matsuhisa, M., & Yamasaki, Y. (2005) · Journal of Molecular Medicine

Endoplasmic Reticulum Stress and DiseaseMetabolism, Diabetes, and Cancer

Cited by 193

High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study

Mori, H., Kuroda, A., Yoshida, S., Yasuda, T., Umayahara, Y., Shimizu, S., Ryomoto, K., Yoshiuchi, K., Yamamoto, T., Matsuoka, T., et al. (2021) · Journal of Diabetes Investigation

Nutrition and Health in AgingDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 90

Evaluation of a Minimally Invasive System for Measuring Glucose Area under the Curve during Oral Glucose Tolerance Tests: Usefulness of Sweat Monitoring for Precise Measurement

Sakaguchi, K., Hirota, Y., Hashimoto, N., Ogawa, W., Hamaguchi, T., Matsuo, T., Miyagawa, J.-I., Namba, M., Sato, T., Okada, S., et al. (2013) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchAdvancements in Transdermal Drug Delivery

Cited by 50

Direct monitoring of in vivo ER stress during the development of insulin resistance with ER stress-activated indicator transgenic mice

Yoshiuchi, K., Kaneto, H., Matsuoka, T.-A., Kohno, K., Iwawaki, T., Nakatani, Y., Yamasaki, Y., Hori, M., & Matsuhisa, M. (2008) · Biochemical and Biophysical Research Communications

Endoplasmic Reticulum Stress and DiseaseMetabolism, Diabetes, and Cancer

Cited by 41

Nasal glucagon as a viable alternative for treating insulin-induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: a phase 3 randomized crossover study

Matsuhisa, M., Takita, Y., Nasu, R., Nagai, Y., Ohwaki, K., & Nagashima, H. (2020) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 27

Lower risk of severe hypoglycaemia with insulin glargine 300 U/ mL versus glargine 100 U/ mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials

Danne, T., Matsuhisa, M., Sussebach, C., Goyeau, H., Lauand, F., Niemoeller, E., & Bolli, G. B. (2020) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 25